Literature DB >> 28148489

Hospital readmissions for COPD in England are rising, audit shows.

Gareth Iacobucci1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28148489     DOI： 10.1136/bmj.j557

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients.

Authors:  Yao-Kuang Wu; Wen-Lin Su; Mei-Chen Yang; Sin-Yi Chen; Chih-Wei Wu; Chou-Chin Lan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-08-30

2.  Predictors of 30- and 90-Day COPD Exacerbation Readmission: A Prospective Cohort Study.

Authors:  Swapna Mandal; John R Hurst; Jaber S Alqahtani; Yousef S Aldabayan; Abdulelah M Aldhahir; Ahmad M Al Rajeh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-10-07

3.  Findings of the Chronic Obstructive Pulmonary Disease-Sitting and Exacerbations Trial (COPD-SEAT) in Reducing Sedentary Time Using Wearable and Mobile Technologies With Educational Support: Randomized Controlled Feasibility Trial.

Authors:  Lauren B Sherar; Sally J Singh; Mark W Orme; Amie E Weedon; Paula M Saukko; Dale W Esliger; Mike D Morgan; Michael C Steiner; John W Downey
Journal:  JMIR Mhealth Uhealth       Date:  2018-04-11       Impact factor: 4.773

4.  Using and implementing care bundles for patients with acute admission for COPD: qualitative study of healthcare professionals' experience in four hospitals in England.

Authors:  Ali Shaw; Katherine Morton; Anna King; Melanie Chalder; James Calvert; Sue Jenkins; Sarah Purdy
Journal:  BMJ Open Respir Res       Date:  2020-03

5.  Observational Cost-Effectiveness Analysis Using Routine Data: Admission and Discharge Care Bundles for Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Padraig Dixon; William Hollingworth; Jonathan Benger; James Calvert; Melanie Chalder; Anna King; Stephanie MacNeill; Katherine Morton; Emily Sanderson; Sarah Purdy
Journal:  Pharmacoecon Open       Date:  2020-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.